KZA (ASX) Ann: Kazia announces change to Board of Directors

Originally posted by Slider19200000 ↑

Adding my perspective for the recent executive changes. Pure speculation but since the decline in the share price and the questionable decisions by the board and mgmt to raise money at the market likely created pressure from large institutional holders for changes. Also, my recent experience in following this message board there has been more and more discussions by all of us focused on the need for senior mgmt changes. Nowadays with online information I would not be surprised even institutional holders and others do read message boards along with mgmt.

My opinion only but the board and mgmt have not executed well.

Both board and mgmt have no influence on the success of the trials as they are all being run by independent third parties and that is what you want for transparency and credibility. But both board and mgmt have failed on executing good regular reporting agreements with these 3rd parties on progress to date and the strategy for capital funding and raising as couple of examples.

Love to hear others thoughts and opinions.

Expand

I tend to agree with you , both Garner and Ross were expensive and not based in the USA where most of the action is.

With the departure of Garner and Ross to be replaced by John Friend, we have effectively got rid of 2 expensive headcounts.

Ross being a substantial shareholder will stand to make a lot of money if Kazia is succesful anyway, maybe it is clearing the decks for an offer from a US based big pharma, who doesn't want to get rid of expensive incumbents.

Also it wasn't that long ago that we appointed Ebru Davidson (June-23) to the board.

Ebru is a highly experienced corporate lawyer and is currently the General Counsel for QBiotics Group Limited, an unlisted public Australian life sciences company that discovers and develops pharmaceuticals derived from nature to address unmet medical needs in humans and companion animals. As a former partner at Thomson Geer Lawyers, Ebru brings over 14 years’ experience in equity capital markets, private and public mergers and acquisitions, corporate transactions and corporate governance. She also has extensive experience in advising listed and unlisted entities on compliance and regulatory matters working closely with the Australian Securities and Investment Commission and Australian Securities Exchange.